| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2013 | CA2603939C Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors |
| 08/27/2013 | CA2599843C Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 08/27/2013 | CA2594690C Salts of aripiprazole |
| 08/27/2013 | CA2584017C Aqueous ophthalmic suspension of crystalline rebamipide |
| 08/27/2013 | CA2572325C Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 08/27/2013 | CA2566315C Use of non-peptide nk1 receptor antagonists for the production of apoptosis in tumour cells |
| 08/27/2013 | CA2566210C Oxo-substituted cyclohexyl-1,4-diamine derivatives |
| 08/27/2013 | CA2554205C Novel inhibitors of chymase |
| 08/27/2013 | CA2543626C Synbiotic composition for infants |
| 08/27/2013 | CA2531868C Process for the preparation of thalidomide |
| 08/27/2013 | CA2526212C Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 08/27/2013 | CA2518774C Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 08/27/2013 | CA2516163C High viscosity xanthan polymer preparations |
| 08/27/2013 | CA2505836C Topical brimonidine tartrate formulations that lack chlorine dioxide |
| 08/27/2013 | CA2462675C Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 08/27/2013 | CA2375980C Compositions, kits, and methods for providing and maintaining energy and mental alertness |
| 08/27/2013 | CA2227301C Hcv binding protein |
| 08/26/2013 | DE202013004793U1 Pflegende Fußcreme zur Beseitigung von Pilzen Nourishing Foot Cream for the elimination of fungi |
| 08/23/2013 | CA2807524A1 Methods and compositions for treating cancer metastasis |
| 08/22/2013 | WO2013123521A1 Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients |
| 08/22/2013 | WO2013123511A1 Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics |
| 08/22/2013 | WO2013123456A1 Linear peptide antibiotics |
| 08/22/2013 | WO2013123444A1 Sulfonyl compounds that interact with glucokinase regulatory protein |
| 08/22/2013 | WO2013123426A1 Formulations and methods for the treatment or prophylaxis of pre-mci and/or pre-alzheimer's conditions |
| 08/22/2013 | WO2013123419A1 N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinoline carboxamide, preparation and uses thereof |
| 08/22/2013 | WO2013123413A2 Combinations of histone deacetylase inhibitor and pazopanib and uses thereof |
| 08/22/2013 | WO2013123401A1 Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv) |
| 08/22/2013 | WO2013123382A1 Dithioamine reducing agents |
| 08/22/2013 | WO2013123335A1 Peripherally restricted diphenyl purine derivatives |
| 08/22/2013 | WO2013123324A1 Gelling agent for use in cosmetic compositions |
| 08/22/2013 | WO2013123320A1 Methods, pharmaceutical compositions, therapeutic systems, and compounds for treating b cell malignancies |
| 08/22/2013 | WO2013123298A1 Nanoparticles for mitochondrial trafficking of agents |
| 08/22/2013 | WO2013123290A1 Methods of treating amyotrophic lateral sclerosis |
| 08/22/2013 | WO2013123272A1 Compositions and improved soft tissue replacement methods |
| 08/22/2013 | WO2013123270A1 Compositions and improved soft tissue replacement methods |
| 08/22/2013 | WO2013123227A1 Formulations of bendamustine |
| 08/22/2013 | WO2013123218A1 Selective estrogen receptor modulators with short half-lives and uses thereof |
| 08/22/2013 | WO2013123215A2 Antiviral drugs for treatment of arenavirus infection |
| 08/22/2013 | WO2013123165A1 Crystalline form of (2s,4r)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1h-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid [1,3]dioxol-4-ylmethyl ester |
| 08/22/2013 | WO2013123151A1 Methods of controlling tumor bioenergetics networks |
| 08/22/2013 | WO2013123148A1 Inhibitors of human immunodeficiency virus replication |
| 08/22/2013 | WO2013123138A2 Spiro [2.4]heptanes for treatment of flaviviridae infections |
| 08/22/2013 | WO2013123083A1 Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis using an aminopyridine |
| 08/22/2013 | WO2013123081A2 Use of small molecule inhibitors targeting the interaction between rac gtpase and p67 (phox) |
| 08/22/2013 | WO2013123071A1 Methods and compositions for jamm protease inhibition |
| 08/22/2013 | WO2013123033A1 Dimethylarginine dimethylaminohydrolase inhibitors and methods of use thereof |
| 08/22/2013 | WO2013123019A1 C-3 cycloalkenyl triterpenoids with hiv maturation inhibitory activity |
| 08/22/2013 | WO2013122953A1 Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators |
| 08/22/2013 | WO2013122920A1 Dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | WO2013122918A1 Methods and compositions for inhibiting a multi-cancer mesenchymal transition mechanism |
| 08/22/2013 | WO2013122897A1 Dihydrobenzoxazine and tetrahydroquinoxaline sodium channel inhibitors |
| 08/22/2013 | WO2013122888A2 Methods of treating bacterial infections |
| 08/22/2013 | WO2013122861A2 Conditioning composition additive for providing immediate and long lasting benefits to keratin substrates |
| 08/22/2013 | WO2013122855A1 Methods of increasing lymphatic transport |
| 08/22/2013 | WO2013122823A1 Enediyne compounds, conjugates thereof, and uses and methods therefor |
| 08/22/2013 | WO2013122778A1 Methods of treating and preventing diseases and disorders of the central nervous system |
| 08/22/2013 | WO2013122624A1 Azetidinone cholesterol absorption inhibitor (ezetimibe) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events |
| 08/22/2013 | WO2013122623A1 Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (cvd) who are deficient in blood epa and dha levels |
| 08/22/2013 | WO2013122622A1 A method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics |
| 08/22/2013 | WO2013122621A1 Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden death |
| 08/22/2013 | WO2013122620A1 Statin and omega 3 fatty acids for reduction of apolipoprotein-b levels |
| 08/22/2013 | WO2013122609A1 Methods of using cdk8 antagonists |
| 08/22/2013 | WO2013122575A2 Small molecule having antiviral properties |
| 08/22/2013 | WO2013122559A1 Composition and methods for quenching free radicals and modulating inflammation |
| 08/22/2013 | WO2013122554A1 Pellet formulations comprising esomeprazole |
| 08/22/2013 | WO2013122553A1 A pharmaceutical formulation comprising an atp-ase inhibitor and method for this formulation |
| 08/22/2013 | WO2013122465A1 Food composition comprising vitamin k and saturated fat and its use |
| 08/22/2013 | WO2013122446A1 Composition for preventing tachycardia during heart pain treatment |
| 08/22/2013 | WO2013122413A1 Oral formulation comprising lansoprazole and the preparation method thereof |
| 08/22/2013 | WO2013122303A1 Novel 2- aminothiazole derivative and anti-cancer composition comprising same as active ingredient |
| 08/22/2013 | WO2013122260A1 Tablet |
| 08/22/2013 | WO2013121452A1 Product comprising glucomannan and chitosan for the treatment gastroesophageal reflux disease |
| 08/22/2013 | WO2013121449A1 Compositions and methods for the modulation of specific amidases for n-acylethanolamines for use in the therapy of inflammatory diseases |
| 08/22/2013 | WO2013121440A1 Process for preparing benzisothiazol-3-yl-peperazin-l-yl-methyl-cyclo hexyl-methanisoindol-1,3-dione and its intermediates |
| 08/22/2013 | WO2013121387A1 Anti -malarial agents |
| 08/22/2013 | WO2013121354A1 Oil-based pharmaceutical composition for the treatment of gastrointestinal diseases |
| 08/22/2013 | WO2013121300A2 Methods for treating psoriasis and vascular inflammation |
| 08/22/2013 | WO2013121233A1 Pharmaceutical formulation having improved stability |
| 08/22/2013 | WO2013121214A1 Reduction of gastrointestinal tract colonisation by campylobacter |
| 08/22/2013 | WO2013121209A1 Novel cyclic phenoxy compounds and improved treatments for cardiac and cardiovascular disease |
| 08/22/2013 | WO2013121190A1 Method for preparing a herbicidal compound |
| 08/22/2013 | WO2013121184A1 Hydrocortisone controlled release formulation |
| 08/22/2013 | WO2013121034A1 Methods and pharmaceutical compositions for reducing adipose tissue inflammation |
| 08/22/2013 | WO2013120980A1 Tricyclic compounds and methods of use therefor |
| 08/22/2013 | WO2013120935A1 Pharmaceutical compositions for combination therapy |
| 08/22/2013 | WO2013120921A1 Novel pyrrolidine derivatives |
| 08/22/2013 | WO2013120896A1 Compound for use in the prevention and/or treatment of a neurogenerative disease or a disease involving an activation of phosphodiesterase-4 (pde4) |
| 08/22/2013 | WO2013120881A1 Method for treating intestinal diseases presenting at least one inflammatory component |
| 08/22/2013 | WO2013120835A1 Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 08/22/2013 | WO2013120771A1 Imidazolylketone derivatives asd aldosterone synthase inhibitors |
| 08/22/2013 | WO2013120466A1 A new solid form of tapentadol and a method of its preparation |
| 08/22/2013 | WO2013120463A1 A method for the manufacture of a polymorphously stable pharmaceutical composition containing agomelatine |
| 08/22/2013 | WO2013120229A1 METHOD FOR PREPARING AQUEOUS MANO PARTICLE SUSPENSIONS OF DERIVATIVES OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURAN ALIPHATIC ACID ESTERS |
| 08/22/2013 | WO2013101983A3 Targeted self-assembly 0f functionalized carbon nanotubes on tumors |
| 08/22/2013 | WO2013101911A3 Benzimidazole derivatives as selective blockers of persistent sodium current |
| 08/22/2013 | WO2013100585A3 Adonis amurensis extract or anti-cancer composition using same as an active ingredient |
| 08/22/2013 | WO2013090523A3 Methods, systems, and compositions for cell-derived/vesicle-based microrna delivery |
| 08/22/2013 | WO2013086379A3 Methods and compositions for treating antiprogestin-resistant cancers |
| 08/22/2013 | WO2013081420A3 Phenoxypropanol derivative and pharmaceutical composition containing same |
| 08/22/2013 | WO2013081400A3 Novel benzamide derivative and use thereof |